888740-22-5

Basic information

• Product Name: 3-[2-hydroxy-4-(2-methoxyethoxy)phenyl]propanoic acid ethyl ester
• Synonyms: 3-[2-hydroxy-4-(2-methoxyethoxy)phenyl]propanoic acid ethyl ester
• CAS NO: 888740-22-5
• Molecular Weight: 268.31
• Mol File: 888740-22-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-[2-hydroxy-4-(2-methoxyethoxy)phenyl]propanoic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[2-hydroxy-4-(2-methoxyethoxy)phenyl]propanoic acid ethyl ester(888740-22-5)
• EPA Substance Registry System: 3-[2-hydroxy-4-(2-methoxyethoxy)phenyl]propanoic acid ethyl ester(888740-22-5)

Safety Data

• Hazardous Substances Data: 888740-22-5(Hazardous Substances Data)

Upstream product

• 888740-21-4 (2E)-3-[2-(benzyloxy)-4-(2-methoxyethoxy)phenyl]acrylic acid ethyl ester 

Downstream Products

• 888740-72-5 3-(4-(2-methoxyethoxy)-2-{[4-(trifluoromethyl)benzyl]oxy}phenyl)propanoic acid ethyl ester 
• 888740-68-9 3-[2-[(2,4-dichlorobenzyl)oxy]-4-(2-methoxyethoxy)phenyl]propanoic acid ethyl ester 
• 888740-23-6 ethyl 3-[2-([3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy)-4-(2-methoxyethoxy)phenyl]propanoate 

Relevant articles and documents

THERAPEUTIC AGENT FOR DIABETES

The present invention provides an agent for the prophylaxis or treatment of diabetes, which is associated with a ferwer side effects such as body weight gain, adipocyte accumulation, cardiac hypertrophy and the like, and which contains a compound represented by the formula: wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.

ARYLALKANOIC ACID DERIVATIVE

A compound represented by the general formula (I): [wherein Ar represents an optionally substituted aromatic ring; Xa, Xc, Ya, Yc, Z1, and Z2 each represents a bond, O, S, -CO-, -CS-, -CR3(OR4)-, -NR5-, -SO-, -SO2-, -CONR6-, or -NR6CO- (R3, R4, R5, and R6 are as defined in the description); Xb and Yb each represents a bond or a C1-20 divalent hydrocarbon group; R1 represents an optionally substituted hydrocarbon group; ring A represents an aromatic ring (other than benzimidazole) which may be further substituted; n is an integer of 1-8; ring B represents an aromatic ring (other than oxazole) which may be further substituted; W represents a C1-20 divalent saturated hydrocarbon group; and R2 represents -OR8 or -NR9R10 (R8, R9, and R10 are as defined in the description)] or a salt of the compound. It is useful as a preventive/therapeutic agent for diabetes, etc.